Digital inhaler tracking for lung disease
Part of Lungs & breathing clinical trials.
This study tests how well a digital device that tracks your inhaler use works for people with lung conditions like COPD or asthma. It's a small initial study to see if this approach is helpful.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a lung condition like COPD or asthma
- You can speak, read, and understand English
- You can use a smartphone or tablet
- You use a daily inhaler (either a dry powder inhaler or a metered dose inhaler)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a home monitoring program for people with COPD (a long-term lung condition) to track symptoms using a phone or tablet. It may help clinicians spot changes earlier and improve how COPD care is managed.
This study tests a smartphone app that helps you learn or improve how to use your inhaler correctly. The app provides education and training to make sure you get the most from your medication.
This study tests a smartphone app designed to help you track and manage your COPD symptoms day-to-day. It includes a small device you use at home to measure your lung function, aiming to help you catch problems early and stay healthier.
This study tests whether wearable medical devices can help monitor your COPD symptoms at home. You will use a smartphone app and a small chest patch to track your breathing, which may help you and your doctor better manage your condition.
This trial tests a smartphone-based program to help people with COPD manage their condition at home. It may help you track symptoms and avoid flare-ups.
This study looks at how well people with COPD or asthma use their inhalers. It aims to understand common problems and find ways to improve treatment adherence.
Hear when a new Chronic Obstructive Airway Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.